Department of Radiotherapy & Oncology, Postgraduate Institute of Medical Education & Research, Chandigarh 160012, India.
Department of Histopathology, Postgraduate Institute of Medical Education & Research, Chandigarh 160012, India.
CNS Oncol. 2020 Dec 1;9(4):CNS63. doi: 10.2217/cns-2020-0016. Epub 2020 Dec 7.
Small cell glioblastoma (scGBM) is a rare histological variant of classical glioblastoma (GBM). Presence of necrosis and microvascular proliferation is not essential for the diagnosis. It is thought to have more aggressive behavior as compared with classical GBM; however, because of its rarity standard treatment guidelines are not available. Adjuvant treatment for these cancers consists of postoperative radiotherapy with concurrent and maintenance temozolomide similar to classical GBM. Here we present a case series of five small cell glioblastoma patients along with the clinical-pathological review.
小细胞胶质母细胞瘤 (scGBM) 是经典胶质母细胞瘤 (GBM) 的一种罕见组织学变体。存在坏死和微血管增生对于诊断并非必需。与经典 GBM 相比,它被认为具有更具侵袭性的行为;然而,由于其罕见性,目前尚无标准的治疗指南。这些癌症的辅助治疗包括术后放疗,同时进行替莫唑胺的同步和维持治疗,类似于经典 GBM。在这里,我们提出了五例小细胞胶质母细胞瘤患者的病例系列,并进行了临床病理复习。